newsfilter
← Latest News
Business Wire·

Sema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed Merger

Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, and CM Life Sciences (NASDAQ:CMLF), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC a